Nephritis - 146 Studies Found

Withdrawn : BRILLIANT-SC: A Study of the Efficacy and Safety of Blisibimod Administration in Subjects With IgA Nephropathy
: IgA Nephropathy
: 2014-01-29
:
  • Drug: Blisibimod Blisibimod ad
Completed : IgA Nephropathy, Lymphocyte Homing and IgA Class Switch
: IgA Nephropathy
: 2013-01-18
: Other: blood test
Completed : Mycophenolate Mofetil for IgA Nephropathy
: IGA Nephropathy
: 2009-03-15
:
  • Drug: mycophenolate mofetil Or
Active, not recruiting : BRIGHT-SC: Blisibimod Response in IgA Nephropathy Following At-Home Treatment by Subcutaneous Administration
: IgA Nephropathy
: 2014-02-12
:
  • Drug: Blisibimod
  • Drug: Placebo
Withdrawn : Paricalcitol for the Treatment of Immunoglobulin A Nephropathy
: IgA Nephropathy
: 2008-01-02
: Drug: paricalcitol paricalcitol 1 mg/day
Recruiting : IgA Nephropathy Biomarkers Evaluation Study (INTEREST)
:
  • IgA Nephropathy
  • Glomerular Diseases

: 2016-11-02
: Other: No intervention No intervention
Terminated : Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy
: IgA Nephropathy
: 2006-04-24
:
  • Drug: Mycophenolate Mofetil (MMF)

Terminated : Diet Intervention in Food Sensitive Patients With IgA Nephropathy
: IGA Nephropathy
: 2010-09-15
:
  • Dietary Supplement: Tailored diet

Completed : Treatment of Patients With Idiopathic Membranous Nephropathy
: Glomerulonephritis, Membranous
: 2005-08-25
: Drug: Cyclophosphamide and steroids comparison of difference in time of start of therapy
Completed : Mycophenolate Mofetil in Membranous Nephropathy
: Glomerulonephritis, Membranous
: 2005-08-25
:
  • Drug: mycophenolate mofetil orally 1000 mg twice a day (BID)
<<< Previous | Next >>>